Evaluation of a Surgical Microscope Mounted Autorefractor When Used on Patients Lying in a Supine Position

April 11, 2013 updated by: Adventus Technology
The purpose of this study is to evaluate the accuracy and repeatability of an individually validated prototype autorefractor designed to be mounted on a surgical microscope.

Study Overview

Detailed Description

The purpose of this study is to evaluate the accuracy and repeatability of an individually validated prototype autorefractor designed to be mounted on a surgical microscope. The goal is to evaluate 20 subjects with both the investigational instrument followed by a commercially available instrument.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Missouri
      • St Louis, Missouri, United States, 63131
        • Ophthalmology Associates

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Be at least 18 years of age as of the date of evaluation for the study.
  2. Have:

    1. Read the Informed Consent
    2. been given an explanation of the Informed Consent
    3. indicated understanding of the Informed Consent
    4. signed the Informed Consent document.
  3. Be willing and able to adhere to the instructions set forth in this protocol and able to participate in all scheduled evaluations.
  4. Be in good general health, based on his/her knowledge.
  5. Have a refractive error within the range of -10.00 to +30.00 Diopter sphere and up to 5.00 Diopter of refractive cylinder .
  6. Have manifest refraction (BCVA) Snellen visual acuities (VA) equal to or better than 20/25 in each eye. -

Exclusion Criteria:

Subjects may not be enrolled in this study if any of the following apply: The subject is/has:

  1. Allergy to Tropicamide or a previous adverse reaction to Tropicamide.
  2. Poor personal hygiene as observed by the investigational site personnel.
  3. Strabismus
  4. Currently pregnant (to the best of the subject's knowledge) or is lactating.
  5. Previous refractive surgery or current or previous orthokeratology treatment.
  6. Aphakic or pseudophakic or has cataracts that interfere with visual acuity.
  7. Ocular or systemic disease such as, but not limited to: anterior uveitis or iritis (past or present), glaucoma, Sjögren's syndrome, lupus erythematosus, sclerodermia, keratoconus or type II diabetes.
  8. The need for topical ocular medications or any medication which might interfere with the study evaluations.
  9. The presence of clinically significant (grade 3 or 4) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids, or associated structures.
  10. Slit lamp findings, including but not limited to:

Pathological dry eye or associated dry eye symptoms with decreased tear levels and punctuate staining > Grade 2 Pterygium Corneal scars within the visual axis Neovascularization or ghost vessels > 1.0 mm in from the limbus Giant papillary conjunctivitis (GPC) of > Grade 2 Anterior uveitis or iritis Seborrheic eczema, seborrheic conjunctivitis or blepharitis

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: DIAGNOSTIC
  • Allocation: NON_RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Intraoperative Autorefractor IAR-1
This is a auto refractor mounted on an operating microscope.
This is an auto-refractor mounted on an operating microscope and used with the subject in a supine position
ACTIVE_COMPARATOR: Hartmann-Shack Auto Refractor
The Hartmann-Shack type auto refractor used with the subject sitting upright in front of the instrument.
Standard auto-refractor used with subject sitting upright in front of the instrument.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of the accuracy and repeatability of the Test device compared to the Control
Time Frame: 1 Hour
Comparative auto refractor device measurement variation is defined as +/-0.25 Diopters
1 Hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gregg Berdy, MD

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2013

Primary Completion (ACTUAL)

March 1, 2013

Study Completion (ACTUAL)

March 1, 2013

Study Registration Dates

First Submitted

March 29, 2013

First Submitted That Met QC Criteria

April 5, 2013

First Posted (ESTIMATE)

April 10, 2013

Study Record Updates

Last Update Posted (ESTIMATE)

April 12, 2013

Last Update Submitted That Met QC Criteria

April 11, 2013

Last Verified

April 1, 2013

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FA120928

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Refractive Error

Clinical Trials on Intraoperative Autorefractor IAR-1

3
Subscribe